Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue-Reference-Cited by-同舟云学术

Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue

Published:2015-05 Issue:5 Volume:74 Page:390-400
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Gielen Paul R.,Schulte Barbara M.,Kers-Rebel Esther D.,Verrijp Kiek,Petersen-Baltussen Harriëtte M.J.M.,ter Laan Mark,Wesseling Pieter,Adema Gosse J.

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://academic.oup.com/jnen/article-pdf/74/5/390/17419874/74-5-390.pdf

Reference41 articles.

1. Louis DN Ohgaki H Wiestler OD . WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer, 2007

2. Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancy

3. CNS immune privilege: hiding in plain sight

4. Gielen P van der Valk P Wesseling P . Immune responses to tumours in the CNS. In: Woodroofe N Amor S , eds. Neuroinflammation and CNS Disorders. Chichester, UK: John Wiley & Sons Ltd, 2014: 363–84

5. Breakthrough of the year 2013;Couzin-Frankel;Cancer immunotherapy. Science,2013

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives;International Immunopharmacology;2024-12

2. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence;International Immunopharmacology;2024-12

3. Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma;Frontiers in Oncology;2024-08-14

4. Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid Cells;Pharmaceutics;2024-07-19

5. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08